164 results
Page 4 of 9
8-K
EX-99.1
nfbfu
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
8-K
EX-99.1
8ruvuo
30 Sep 21
Regulation FD Disclosure
1:30pm
8-K
EX-99.1
kgbo 98zva5q1k
24 Sep 21
InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update
4:07pm
10-K
bhgbo3xao
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
zww vieqa
24 Sep 21
Annual report
7:31am
8-K
EX-99.1
ahq732z8 4rw72qm3
20 Sep 21
Regulation FD Disclosure
1:09pm
8-K
EX-99.2
lriyqn1j1skj6pe
20 Sep 21
Regulation FD Disclosure
1:09pm
8-K
EX-99.1
9bb ct2475i
13 Sep 21
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids
8:00am
8-K
EX-99.1
8yejuo1 0utmlrjtp
10 Sep 21
InMed Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
6:13am
8-K
EX-99.1
lklxdcw
8 Sep 21
Regulation FD Disclosure
6:04am
8-K
EX-99.1
uc42u
12 Aug 21
InMed Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference
3:33pm
424B3
kl7wcl
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-99.1
3flucs134i
2 Jul 21
InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement
4:27pm
8-K
EX-99.1
0ynyhp9j5laekptwrc
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am